{"id":"W4390572101","doi":"10.1182/bloodadvances.2023011735","title":"Outcomes of intensive and nonintensive blast-reduction strategies in accelerated and blast-phase MPN","year":2024,"lang":"en","type":"article","venue":"Blood Advances","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre","funders":"Astellas Pharma; Leukemia and Lymphoma Society of Canada; Celgene; Sierra Oncology; Leukemia and Lymphoma Society; Princess Margaret Cancer Foundation; Amgen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Cytarabine; Internal medicine; Daunorubicin; Gastroenterology; Myeloid leukemia; Confidence interval; Retrospective cohort study; Odds ratio; Myeloid; Hypomethylating agent; Oncology; Leukemia; Biology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005294466,0.0001893294,0.0004402479,0.000177226,0.00003221203,0.00004715886,0.0000217215,0.00005186626,0.00002851122],"category_scores_gemma":[0.00014024,0.0001330772,0.00003958623,0.0001857255,0.0001726387,0.0003101086,0.00002732634,0.0001276698,0.000003079087],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001663121,"about_ca_system_score_gemma":0.00007966381,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005121439,"about_ca_topic_score_gemma":0.00009695332,"domain_scores_codex":[0.999098,0.00002498212,0.0002679953,0.0003268548,0.0001241617,0.000158019],"domain_scores_gemma":[0.9992865,0.0001293528,0.0000581293,0.00009160789,0.0003610723,0.00007328956],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00233021,0.004375698,0.7127512,0.003017913,0.004033099,0.002963474,0.01915892,0.0001898559,0.1022946,0.01833804,0.001000753,0.1295462],"study_design_scores_gemma":[0.02195255,0.008697722,0.4984402,0.003433398,0.001742872,0.001756925,0.06392435,0.001410559,0.3905081,0.003248679,0.004051049,0.0008336547],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9851322,0.01241447,0.00001857563,0.001399091,0.0001703944,0.000405053,0.00002989468,0.00003754268,0.0003927955],"genre_scores_gemma":[0.9955124,0.003510418,0.0005458463,0.0001445185,0.00004933943,0.00005572584,0.00001848557,0.00001461488,0.0001486166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2882135,"threshold_uncertainty_score":0.5426731,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02021642297003689,"score_gpt":0.3423091176300899,"score_spread":0.322092694660053,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}